HR 4114
Allergy Testing Access Act of 2021
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Bill overview
The Allergy Testing Access Act of 2021 aims to ensure equal coverage for allergy testing under Medicare and Medicaid. Specifically, it mandates that in vitro specific IgE tests (blood tests) and percutaneous tests (skin tests) are treated the same regarding medical necessity, frequency limits, and allergen unit limits. This bill seeks to improve health outcomes, reduce healthcare costs, and address disparities in access to allergy diagnostics by aligning coverage policies across these programs.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsors
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.